Overview
Adipose Tissue Storage in the Rapid Remission of Hepatic and Cardiac Metabolic Dysfunction After Bariatric Surgery
Status:
Recruiting
Recruiting
Trial end date:
2028-05-01
2028-05-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The present protocol aims to understand and establish whether there is a causal link between adipose tissue metabolic remodeling and Type 2 Diabetes (T2D) remission after bariatric surgery. All participants will have a bariatric surgery, divided in 2 groups: with or without T2D.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Université de SherbrookeCollaborators:
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Institut universitaire de cardiologie et de pneumologie de Québec, University LavalTreatments:
Niacin
Niacinamide
Nicotinic Acids
Criteria
Inclusion Criteria:- Aged 18 to 65
- BMI 35 kg/m2
- Diagnosed T2D - according to Diabetes Canada diagnostics criteria.
- Diagnosed non-T2D - according to Diabetes Canada diagnostics criteria.
- Women with a negative serum pregnancy test.
Exclusion Criteria:
- Treatment with an oral contraceptive;
- Treatment with fibrate, thiazolidinedione, insulin, or beta-blocker, drugs that affect
metabolism and cannot be stopped temporarily or which have long-lasting effects;
- Presence of overt cardiovascular disease, liver or renal failure or other uncontrolled
medical conditions;
- Any other contraindication to surgery or to temporarily suspending current medications
for diabetes, lipids or hypertension;
- Smoking or consumption of more than 2 alcoholic beverages per day;
- Any contraindication to MRI;
- A Diabetes Remission (DiaRem) score >8 (low probability of T2D remission);
- Having participated to a research study with exposure to radiation in the last two
years before the start of the study;
- Pregnant or breastfeeding women;
- Patients weighing more than 200 kg to respect the weight and gantry limit of our MRI
and PET/CT scanners.
- Being allergic to eggs